Interferon may prevent HIV viral rebound after HAART interruption in HIV patients.

@article{Dianzani2008InterferonMP,
  title={Interferon may prevent HIV viral rebound after HAART interruption in HIV patients.},
  author={Ferdinando Dianzani and Gabriella Rozera and Isabella Abbate and Gianpiero D'offizi and Amina Abdeddaim and Chrysoula Vlassi and Giorgio Antonucci and Pasquale Narciso and Federico Martini and Maria Rosaria Capobianchi},
  journal={Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research},
  year={2008},
  volume={28 1},
  pages={1-3}
}
In the pre-highly active antiretroviral therapy (HAART) era, clinical trials showed that interferon (IFN) treatment was able to delay AIDS progression and prolong survival. Along with HAART, ancillary use of IFN during primary infection and before HAART therapy initiation has been effective. Also endogenous IFN may positively affect the progression of HIV infection, as suggested in GB virus type C (GBV-C) coinfected patients. In this pilot study, we tried to prevent rebound of HIV replication… CONTINUE READING